The Enhanced Games — tech’s steroid extravaganza — didn’t pay off, as company posts $60 million loss
An effort to transform the world of sports through steroid use doesn't exactly seem to be bearing financial fruit.
Последние новости
⚑ Сообщить о проблемеTech news from the best sources
Все темы
AI
Gear
News
Tech
agents
ai
api
architecture
automation
beginners
career
database
devchallenge
devops
javascript
llm
machinelearning
mcp
opensource
performance
productivity
programming
python
react
security
showdev
testing
tutorial
typescript
webdev
Dimension Capital’s $800M third fund shows the intersection of science and compute is booming
The four-year-old firm's latest fund is 60% larger than its second vehicle announced 18 months ago.
On the run for 20 years, most-wanted fugitive caught hiding as a biotech exec
Ronald Fischer, aka Richard Graydon, was arrested in New York last week.
Building Kuwait Drug Prices: Why We Moved from React to Astro
Finding the official listed price of a medicine in Kuwait should not be difficult. The information exists in price lists published by the Kuwait Min…
What happens in Vega$: steroids, swimmers, and a billion-dollar hustle
The Enhanced Games — a singular sporting competition where a majority of the athletes were on performance enhancing drugs — may herald a new busines…
I went to the so-called ‘steroid Olympics,’ to understand why Silicon Valley is obsessed with peptides
The Enhanced Games — a singular sporting competition where a majority of the athletes were on performance enhancing drugs — may herald a new busines…
This young startup is taking on a fragrance industry that hasn’t changed in a almost half century
Fragrance tech company Patina announced Thursday a $2 million raise from investors, including Betaworks and True Ventures.
Imperagen raises £5 million to use quantum physics, AI on enzyme engineering
Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and N…
What Nanochon's Series A Tells Us About the Bio 3D Printing Commercialization Threshold
A $2,000 Implant and a Multi-Million Dollar Question In early 2025, Nanochon closed a Series A round to commercialize its 3D-printed cartilage scaff…